Swissmedic Plans Database for Swiss GDP Certificates
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Swissmedic plans, similar to the European Medicine Agency's (EMA) EudraGMDP data, to bring a SwissGMDP database into operation, which will list the GMP and GDP certificates of all companies in Switzerland with a valid establishment licence issued by Swissmedic.
A press release dated 10 September 2023 states: "The certificates in the SwissGMDP database will include all authorised activities, i.e. unlike EudraGMDP, the GDP activities and Switzerland-specific GMP activities of Swiss companies will also be listed in the certificates. All companies, authorities and individuals can easily view a company's GMP/GDP status using the SwissGMDP database."
An exact date for the activation has not yet been set. The database is expected to be launched on the Swissmedic website in the last first quarter of 2024.
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


